Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia
Evidence on long-term effectiveness and cost effectiveness of treatment sequences for multiple myeloma (MM) is sparse. We used published data and country-specific data to assess the cost effectiveness of four-line treatment sequences for elderly transplant-ineligible patients with MM in Serbia.
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2020-04-01
|
Series: | Slovenian Journal of Public Health |
Subjects: | |
Online Access: | https://doi.org/10.2478/sjph-2020-0011 |
_version_ | 1819096013363740672 |
---|---|
author | Vukićević Đurđa Rochau Ursula Savić Aleksandar Schaffner Monika Jevđević Milica Stojkov Igor Sroczynski Gaby Willenbacher Wolfgang Jahn Beate Siebert Uwe |
author_facet | Vukićević Đurđa Rochau Ursula Savić Aleksandar Schaffner Monika Jevđević Milica Stojkov Igor Sroczynski Gaby Willenbacher Wolfgang Jahn Beate Siebert Uwe |
author_sort | Vukićević Đurđa |
collection | DOAJ |
description | Evidence on long-term effectiveness and cost effectiveness of treatment sequences for multiple myeloma (MM) is sparse. We used published data and country-specific data to assess the cost effectiveness of four-line treatment sequences for elderly transplant-ineligible patients with MM in Serbia. |
first_indexed | 2024-12-21T23:52:26Z |
format | Article |
id | doaj.art-ae8c1e9efaa74d23a4f7eff1b15b8f43 |
institution | Directory Open Access Journal |
issn | 1854-2476 |
language | English |
last_indexed | 2024-12-21T23:52:26Z |
publishDate | 2020-04-01 |
publisher | Sciendo |
record_format | Article |
series | Slovenian Journal of Public Health |
spelling | doaj.art-ae8c1e9efaa74d23a4f7eff1b15b8f432022-12-21T18:45:54ZengSciendoSlovenian Journal of Public Health1854-24762020-04-01592839110.2478/sjph-2020-0011sjph-2020-0011Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in SerbiaVukićević Đurđa0Rochau Ursula1Savić Aleksandar2Schaffner Monika3Jevđević Milica4Stojkov Igor5Sroczynski Gaby6Willenbacher Wolfgang7Jahn Beate8Siebert Uwe9UMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaUniversity of Novi Sad, Faculty of Medicine, Clinical Center of Vojvodina, Clinic for Hematology, SerbiaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaMedical University, Internal Medicine V, Hematology and Oncology, Innsbruck, AustriaUMIT - University for Health Sciences, Medical Informatics and Technology, Department of Public Health, Health Services Research and Health Technology Assessment, Institute of Public Health, Medical Decision Making and HTA, Eduard Wallnöfer Zentrum 1, Hall in Tirol, 6060AustriaArea 4 Health Technology Assessment and Bioinformatics, ONCOTYROL - Center for Personalized Cancer Medicine, Innsbruck, AustriaEvidence on long-term effectiveness and cost effectiveness of treatment sequences for multiple myeloma (MM) is sparse. We used published data and country-specific data to assess the cost effectiveness of four-line treatment sequences for elderly transplant-ineligible patients with MM in Serbia.https://doi.org/10.2478/sjph-2020-0011multiple myelomasequential treatmentlong-term effectivenesscost effectivenessmultipli mielomzaporedno zdravljenjedolgoročna uspešnoststroškovna učinkovitost |
spellingShingle | Vukićević Đurđa Rochau Ursula Savić Aleksandar Schaffner Monika Jevđević Milica Stojkov Igor Sroczynski Gaby Willenbacher Wolfgang Jahn Beate Siebert Uwe Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia Slovenian Journal of Public Health multiple myeloma sequential treatment long-term effectiveness cost effectiveness multipli mielom zaporedno zdravljenje dolgoročna uspešnost stroškovna učinkovitost |
title | Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia |
title_full | Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia |
title_fullStr | Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia |
title_full_unstemmed | Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia |
title_short | Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia |
title_sort | long term effectiveness and cost effectiveness of multiple myeloma treatment strategies for elderly transplant ineligible patients in serbia |
topic | multiple myeloma sequential treatment long-term effectiveness cost effectiveness multipli mielom zaporedno zdravljenje dolgoročna uspešnost stroškovna učinkovitost |
url | https://doi.org/10.2478/sjph-2020-0011 |
work_keys_str_mv | AT vukicevicđurđa longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT rochauursula longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT savicaleksandar longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT schaffnermonika longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT jevđevicmilica longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT stojkovigor longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT sroczynskigaby longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT willenbacherwolfgang longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT jahnbeate longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia AT siebertuwe longtermeffectivenessandcosteffectivenessofmultiplemyelomatreatmentstrategiesforelderlytransplantineligiblepatientsinserbia |